ROCHESTER, Minn. – Researchers at Mayo Clinic are one step closer to individualizing treatment for advanced prostate cancer patients.
They tried to answer this question: “Which are the genes which we can identify in advanced prostate cancer patients which will tell us that a particular drug will work,” Manish Kohli, M.D., the study’s principal investigator, said.
Researchers found genetic clues that suggest whether a patient’s body will accept or resist a certain treatment.
While the findings won’t necessarily help patients tomorrow, they will help researchers know which genes to look for in a patient’s blood to individualize treatment in the future.
“We are going to find the genetic make-up of each patient’s cancer in their blood, and based on the information of which… genes we now have to look for, which we didn’t know before, now we will target it to those genes,” Kohli said.
By individualizing treatment, advanced prostate cancer patients will be able to have precise treatment with the least amount of side effects.